WVE Q4 2021 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-81.3% YoY

Gross Profit

-$24M-1359.5% margin

Operating Income

-$36M-2045.9% margin

Net Income

-$35M-1970.8% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

-95.2%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$207M

Total Liabilities

$175M

Stockholders' Equity

$32M

Cash & Equivalents

$151M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$9M	-81.3%
Gross Profit	-$24M	-$21M	-16.5%
Operating Income	-$36M	-$30M	-19.1%
Net Income	-$35M	-$29M	-20.8%